Home » Market News » DirectorsTalk Highlights » MND Association welcomes report on benefits and terminal illness
Oxford BioDynamics

MND Association welcomes report on benefits and terminal illness

A report revealing terminally ill people face devastating and far-reaching financial hardship because of a ‘made-up policy fudge’ has been welcomed by the Motor Neurone Disease (MND) Association.

The All Party Parliamentary Group for Terminal Illness report found that the current benefits system rule that a person must have six months or less to live to get fast access to benefits is ‘outdated, arbitrary and not based on clinical reality’.

Sally Light, chief executive of the MND Association, says: “These findings add yet more weight to our call for the Government to change the rules as a matter of urgency.

“Our Scrap 6 Months campaign has been gathering momentum over the last year and the report provides further evidence that the rules, as they stand, just don’t work for people who are terminally ill, including those with MND”

Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases. OBD has been granted a substantial funding award from Innovate UK to develop and validate diagnostic, prognostic and predictive EpiSwitch™ biomarkers for ALS.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.